As the COVID-19 pandemic continues to spread, scientists and health care providers are seeking ways to keep the coronavirus from infecting tissues once they're exposed. A new study suggests luring the virus with a decoy - an engineered, free-floating receptor protein - binds the virus and blocks infection.The stud was published in the journal Science.
To infect a human cell, a virus must first bind to a receptor protein on the surface of the cell. SARS-CoV-2, the coronavirus that causes COVID-19, binds to a receptor called ACE2, which plays a number of roles in regulating blood pressure, blood volume, and inflammation. It is found in tissues throughout the body, but especially in the lungs, heart, arteries, kidneys and intestines. Many researchers hypothesize that the host of symptoms associated with COVID-19 may stem from the coronavirus binding to ACE2 and keeping it from doing its job.
"Administering a decoy based on ACE2 might not only neutralize infection, but may have the additional benefit of rescuing lost ACE2 activity and directly treating aspects of COVID-19," the senior author said.
As a potential therapeutic agent, a decoy receptor has one advantage over other drugs: To evade it, the virus would have to mutate in a way that would make it less infectious.
"A benefit of a decoy receptor is that it closely resembles the natural receptor. Therefore, the virus cannot easily adapt to escape neutralization without simultaneously losing its ability to bind to its natural receptor. This means the virus has limited ability to acquire resistance," the author said.
Although ACE2 binds to SARS-CoV-2, it is not optimized for that purpose, which means that subtle mutations to the receptor could make it bind more strongly. This makes it an ideal candidate for a decoy receptor, the author said.
The authors examined more than 2,000 ACE2 mutations and created cells with the mutant receptors on their surfaces. By analyzing how these interacted with the coronavirus, they found a combination of three mutations that made a receptor that bound to the virus 50 times more strongly, making it a much more attractive target for the virus.
They then made a soluble version of the engineered receptor. Detached from cells, the soluble receptor is suspended in solution and free to interact with the virus as a decoy receptor.
The authors verified the strong affinity between the virus and the decoy receptor, rivaling the best antibodies identified to dat.. Furthermore, they found that the decoy receptor not only binds to the virus in live tissue cultures, it effectively neutralizes it, preventing cells from becoming infected.
Further work is required to determine whether the decoy receptors could be an effective treatment of or preventive agent against COVID-19.
"We are testing whether the decoy receptor is safe and stable in mice, and if successful, we then hope to show treatment of disease in animals. Hopefully that data can facilitate a clinical trial," the author said.They are also exploring how the decoy receptor bonds to other coronaviruses with potential to become future pandemics if they cross from bats to humans.
https://news.illinois.edu/view/6367/648208097
https://science.sciencemag.org/content/early/2020/08/03/science.abc0870
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fengineering-human-ace2&filter=22
Mutated (decoy) SARS-CoV-2 human receptor neutralizes coronavirus in cell cultures with high affinity
- 1,611 views
- Added
Edited
Latest News
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Mapping microbiome in metas…
By newseditor
Posted 22 Apr
Full-length mRNA packaged i…
By newseditor
Posted 22 Apr
Other Top Stories
New regulator in iron metabolism in mice
Read more
Does the sex of a cell matter in research?
Read more
Natural sugar to reduce atherosclerotic plaque through increased au…
Read more
Ribosomes revolutionize the way we think about gene expression and…
Read more
New way to think about DNA replication!
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Neuronal activity rapidly r…
By newseditor
Posted 22 Apr
A perspective on muscle phe…
By newseditor
Posted 22 Apr
Foxp1 suppresses cortical a…
By newseditor
Posted 22 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar